Softwr

Healthcare · head to head

Fujifilm Synapse vs Therapixel

Fujifilm Synapse logo

Fujifilm Synapse

Healthcare

Enterprise imaging platform covering PACS, VNA, cardiology and 3D from Fujifilm Healthcare

From
On request
Rated
-
Full reviewWebsite
Therapixel logo

Therapixel

Healthcare

French mammography AI with FDA clearances for 2D and tomosynthesis breast screening

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Fujifilm Synapse pACS, VNA, Cardiovascular and 3D are separately licensed and separately versioned, so an enterprise deployment means four upgrade cycles and four support relationships under one brand rather than one platform upgrade.; Therapixel european and American regulatory positions were established under different regimes, and under the EU Medical Device Regulation this class of diagnostic AI faces a higher classification and notified body scrutiny, so European buyers must verify the current MDR certificate and expiry rather than relying on a legacy CE reference.
  • They diverge on capability: Fujifilm Synapse covers Synapse PACS, Therapixel covers MammoScreen 2D.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Fujifilm Synapse and Therapixel actually diverge.

Attributes where Fujifilm Synapse and Therapixel differ
AttributeFujifilm SynapseTherapixel
PlatformsWeb, Windows, iOS, AndroidWeb

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Fujifilm Synapse

  • Synapse PACS
  • Synapse VNA
  • Synapse Cardiovascular
  • Synapse 3D
  • Synapse Mobility
  • Deconstructed PACS support
  • Cloud services

Only in Therapixel

  • MammoScreen 2D
  • MammoScreen DBT
  • One to ten suspicion score
  • Summary report
  • Workstation and PACS delivery
  • Reading workflow configurations

What people use each for

The jobs each tool is most often brought in to do.

Fujifilm Synapse

  • A hospital replacing PACS that wants the archive decoupled from its scanner vendor so future modality purchases stay competitivenot Therapixel
  • A health system consolidating radiology, cardiology, ophthalmology and wound images into one vendor neutral archive with a single retention policynot Therapixel
  • An outpatient imaging chain that needs one worklist across multiple sites and radiologists reading remotelynot Therapixel
  • A site pursuing a deconstructed PACS strategy that wants to replace the viewer later without touching the archivenot Therapixel

Therapixel

  • A European breast screening programme running mandatory double reading that wants to evaluate AI as a concurrent or second reader within what national guidance permitsnot Fujifilm Synapse
  • An American breast centre that has moved to tomosynthesis and needs reading support on DBT specifically, which Therapixel holds a clearance fornot Fujifilm Synapse
  • A screening service wanting a graded suspicion score rather than a binary flag so readers can calibrate their own thresholdnot Fujifilm Synapse
  • A radiology group evaluating multiple mammography AI vendors head to head on their own historic case set before committingnot Fujifilm Synapse

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Fujifilm Synapse

  • PACS, VNA, Cardiovascular and 3D are separately licensed and separately versioned, so an enterprise deployment means four upgrade cycles and four support relationships under one brand rather than one platform upgrade.
  • Synapse 3D is licensed by concurrent user and sized from average concurrency, which leaves radiologists queued for advanced visualisation at the morning reading peak and forces an unplanned licence purchase.
  • As an independent informatics vendor Fujifilm has less privileged access to proprietary modality data than Philips or Siemens have on their own scanners, so some vendor specific post processing is not available.
  • The vendor neutral archive absorbs non DICOM object types only after per specialty configuration work, and departments such as ophthalmology and dermatology usually need bespoke ingestion projects that were not in the original scope.
  • Migrating a decade of priors from a legacy archive is a large professional services line that Fujifilm quotes separately, and these migrations regularly run past the contracted go live date.

Therapixel

  • European and American regulatory positions were established under different regimes, and under the EU Medical Device Regulation this class of diagnostic AI faces a higher classification and notified body scrutiny, so European buyers must verify the current MDR certificate and expiry rather than relying on a legacy CE reference.
  • MammoScreen does mammography only, so a hospital wanting AI across head CT, chest and breast needs several vendors and several PACS integrations, or an orchestration layer bought from someone else.
  • Therapixel is a small French company competing against Hologic and iCAD, which have incumbency inside the mammography reading workstation, so integration into an American breast centre is more work than it is for the workstation vendor own AI.
  • Detection performance is sensitive to the mammography unit vendor and acquisition protocol, so published results do not transfer between estates and each site needs local validation it must fund itself.
  • Whether AI can substitute for one of two human readers is a national workforce and liability question, not a product capability, so the labour saving that justifies the purchase in one country is not permitted in another.

Pricing, plan by plan

Fujifilm Synapse

On request
  • Synapse$undefined/year
    • Each module licensed separately: PACS, VNA, Cardiovascular, 3D
    • Priced by annual study volume and concurrent diagnostic users
    • Synapse 3D licensed by concurrent user, separate from PACS

Therapixel

On request
  • MammoScreen$undefined/year
    • Priced per examination or by annual screening volume
    • 2D and tomosynthesis licensed by the versions cleared for each
    • Cloud or on premises deployment quoted differently

Which should you pick?

Choose Fujifilm Synapse if

  • You need synapse pacs.
  • You work on Web, Windows, iOS, Android.
  • You also want synapse vna.
Fujifilm Synapse review

Choose Therapixel if

  • You need mammoscreen 2d.
  • You also want mammoscreen dbt.
Therapixel review

Questions people ask

Is Fujifilm Synapse or Therapixel better?
Neither clearly leads. Fujifilm Synapse starts at On request and Therapixel at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Fujifilm Synapse or Therapixel?
Fujifilm Synapse starts at On request and Therapixel at On request.
Does Fujifilm Synapse or Therapixel run on more platforms?
Fujifilm Synapse runs on Web, Windows, iOS, Android. Therapixel runs on Web.
What is Fujifilm Synapse best used for?
Fujifilm Synapse is most often used for a hospital replacing pacs that wants the archive decoupled from its scanner vendor so future modality purchases stay competitive, a health system consolidating radiology, cardiology, ophthalmology and wound images into one vendor neutral archive with a single retention policy, an outpatient imaging chain that needs one worklist across multiple sites and radiologists reading remotely, a site pursuing a deconstructed pacs strategy that wants to replace the viewer later without touching the archive. Of those, a hospital replacing pacs that wants the archive decoupled from its scanner vendor so future modality purchases stay competitive and a health system consolidating radiology, cardiology, ophthalmology and wound images into one vendor neutral archive with a single retention policy are not what Therapixel is typically brought in for.
What can Fujifilm Synapse do that Therapixel cannot?
Fujifilm Synapse covers Synapse PACS, Synapse VNA, Synapse Cardiovascular, Synapse 3D. Therapixel covers MammoScreen 2D, MammoScreen DBT, One to ten suspicion score, Summary report.

Answered from the vendors’ own pages

Fujifilm Synapse: Is Synapse one product or several?

Several. Synapse PACS, Synapse VNA, Synapse Cardiovascular and Synapse 3D are separately licensed products under one brand. Price and scope each one individually.

Therapixel: Is MammoScreen FDA cleared?

Yes. It holds 510(k) clearance K192854 for two dimensional mammography from July 2020, a November 2021 clearance for digital breast tomosynthesis, and two further clearances in October 2024 for later versions.

Fujifilm Synapse: Do I have to buy Fujifilm scanners?

No. Fujifilm sells Synapse independently of imaging hardware, which is a large part of why it wins competitive PACS replacements at mixed fleet sites.

Therapixel: Is it CE marked?

Yes, but European buyers should ask specifically for the current certificate under the Medical Device Regulation and its expiry date, because this class of diagnostic AI moved to a higher classification under MDR.

Fujifilm Synapse: Does Synapse publish pricing?

No. Pricing is quoted by study volume, concurrent users, module mix and storage capacity.

Therapixel: What does the one to ten score mean?

It is a graded suspicion score per finding and per study, designed to be integrated alongside a radiologist BI-RADS assessment rather than treated as a positive or negative result.

Fujifilm Synapse: Can Synapse VNA store non radiology images?

Yes, including visible light, ophthalmology and wound photography, but each specialty typically needs its own ingestion and metadata configuration project.

Therapixel: Does it cover anything besides mammography?

No. It is a mammography product only, including tomosynthesis. Other body regions need a different vendor.

Share

Related pages

More on Fujifilm Synapse

More on Therapixel

Keep looking

Other head to heads